Nanotherapeutics Bohumil s.r.o.

About Nanotherapeutics Bohumil s.r.o.

Nanotherapeutics s.r.o. is a fully owned subsidiary of Nanotherapeutics, Inc., a biologics focused contract development and manufacturing organization (CDMO) serving both government and commercial clients. Capabilities of Nanotherapeutics, Inc. include a pilot facility for performing optimization of upstream, downstream and formulation functions, bulk cGMP manufacturing including Biosafety level-3 (BSL-3), and analytical development for proteins, antibodies, viral vaccines and gene therapy drug products. The Company provides expertise from preclinical through FDA licensure in a variety of production platforms, including microbial and mammalian cell culture and its proprietary serum protein-free Vero cell platform, a highly versatile platform that has been developed and utilized to deliver a wide range of candidate and licensed vaccines against emerging viral diseases.
YEAR FOUNDED:
1999
LEADERSHIP:
CEO: Prasad S. Raje
CFO: James M. Matthew
CSO: Ron Cobb
JOBS:
Please click here for Nanotherapeutics job opportunities.